[EN] HETEROARYL-SUBSTITUTED MACROCYCLIC FLU ENDONUCLEASE INHIBITORS<br/>[FR] INHIBITEURS MACROCYCLIQUES D'ENDONUCLÉASE DE LA GRIPPE SUBSTITUÉS PAR HÉTÉROARYLE
申请人:JANSSEN BIOPHARMA INC
公开号:WO2021191872A1
公开(公告)日:2021-09-30
The present invention relates to heteroaryl-substituted macrocyclic compounds and prodrugs thereof, and pharmaceutically acceptable salts, solvates, and polymorphs thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family.
本发明涉及杂环取代的大环化合物及其前药,以及其药学上可接受的盐、溶剂化合物和多型体,以及将这些化合物作为药物的用途,特别是用于预防和/或治疗由属于Orthomyxoviridae家族的病毒引起的病毒感染。本发明还涉及该化合物的药物组合物或混合制剂,以及用作药物的组合物或制剂,更好地用于预防或治疗由属于Orthomyxoviridae家族的病毒引起的病毒感染。